Companies

See how salaries can vary from company to company

Onit provides project collaboration, business process automation and information management software solutions. view company details

Premier Research is a provider of project management, clinical research and monitoring services for pharmaceutical and medical device companies. view company details

Turner Industries is a provider of project management and heavy hauling services for the construction sector. view company details

Wrike develops a SaaS-based platform that offers workplace collaboration and project management solutions for businesses. view company details

Hill International, Inc. provides project and construction management, and other consulting services primarily for the buildings, transportation, environmental, energy, and industrial markets. The company offers program management, project management, construction management, project management oversight, troubled project turnaround, staff augmentation, project labor agreement consulting, commissioning, estimating and cost management, and labor compliance and facilities management services. It primarily serves the United States federal, state and local governments, as well as other national go... view company details

Westwater Resources, Inc. operates as a diversified energy materials development company. The company's principal project is the Coosa graphite project covering an area of approximately 41,964 acres situated in east-central Alabama. It also holds interest in three lithium brine exploration projects, which include Columbus Basin project in western Nevada; the Railroad Valley project in east-central Nevada; and the Sal Rica Project in northwestern Utah. It addition, the company holds interest in various uranium projects in New Mexico and Texas. The company was formerly known as Uranium Resources... view company details

Primavera Systems, Inc was a private company providing Project Portfolio Management (PPM) software to help project-intensive organizations identify, prioritize, and select project investments and plan, manage, and control projects and project portfolios of all sizes. On January 1, 2009 Oracle Corporation took legal ownership of Primavera. Joel Koppelman, Les Seskin and Dick Faris founded Primavera Systems, Inc. on May 1, 1983. It traded as a private company based in Pennsylvania (USA), developing software for the Project Portfolio Management market. To help expand its product capabilities, Pr... view company details

■ Public involvement ■ Education and outreach ■ Strategic planning For each project, we take the time to listen to our clients, understand the core goals of the project, and design a strategy that produces clear results. Our clients appreciate our honesty, creativity, direct communication style, and ability to flex with changing circumstances. view company details

Rare Element Resources Ltd. explores for mineral properties in the United States. It holds a 100% interest in the Bear Lodge property that comprises the Bear Lodge REE project and the Sundance Gold project located in central Crook County, northeast Wyoming. Rare Element Resources Ltd. is headquartered in Littleton, Colorado. view company details

NH Learning Solutions provides information technology, desktop applications, project management, and business skills training courses. view company details

LMI is a non-profit consulting firm that offers digital analytics, logistics and project management services to the government sector. view company details

Rock Central is a PR firm that provides accounting, project management, information security and HR administration services for businesses. view company details

TRACON Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer and wet age-related macular degeneration (AMD). Its lead product candidate is TRC105, an endoglin antibody, which is in randomized Phase III clinical trial for angiosarcoma; Phase I/II clinical trial for hepatocellular carcinoma; Phase I clinical trial for lung cancer; Phase I/II clinical trial for breast cancer; Phase II clinical trials for prostate cancer; and randomized Phase II clinical trial for wet AMD. The company also develops TRC102, a small molecule t... view company details

Epizyme, Inc., a late-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases primarily in the United States. The company's lead products candidate is tazemetostat, an inhibitor of the EZH2 histone methyltransferase, which is in the Phase II clinical trial for patients with relapsed or refractory non-hodgkin lymphoma (NHL); Phase II clinical trial for relapsed or refractory patients with mesothelioma characterized by BAP1 loss-of-function; and Phase II clinical trial for adults and Phase I clinical trial fo... view company details

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. The company's lead products consist of four ophthalmology development programs across three targets, including X-linked retinoschisis that is in Phase I/II clinical trials; X-linked retinitis pigmentosa, which is in Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials for the treatment of inherited retinal diseases, as well as a preclinical program in adrenoleukodystrophy, which i... view company details

Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. It focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. The company is developing Zygel, a transdermal cannabidiol gel, which is in Phase II clinical trial for treating children and adolescent patients with developmental and epileptic encephalopathies; is in Phase II/III clinical trial to treat children and adolescent patients with fragile X syndrome; and is in Phase II clinical trial for treating children and adolescent pa... view company details

Industrial Molds Group specializes in all facets of injection mold manufacturing including design, engineering, tooling, and special machining services. We're equally adept at developing new tools, design optimization, or reworking existing tools. Regardless of the scope or size of the project, our project management methods, technological expertise, and quality standards set us apart from our competitors. view company details

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the Phase III clinical trial for the treatment resistant depression; Phase II/III clinical trials in agitation associated with Alzheimer's disease; and Phase II clinical trial for the treatment of smoking cessation, as well as for major depressive disorder. The company is also developing AXS-07, which is in Phase III clinical trial for the treatment of migraine; AXS-12 that... view company details

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor(KPT-330), which is in Phase IIb clinical study in treatments of refractory multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for multiple myeloma patients; Phase III clinical trial in combination with Velcade (bortezomib) and dexamethasone for multiple myeloma patients; Phase IIb cli... view company details

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform. The company's lead product candidate is RGX-314, which is in Phase I/IIa clinical trials for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase ... view company details